Search Results
The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.
Filter your results:
Types
Topics
192 Results Found
AHA 340B Advocacy Alliance Bulletin - January 12, 2026
Several health care groups, including the AHA, today told the Centers for Medicare & Medicaid Services it is wrong to tell hospitals and health systems they “are to” complete the agency’s Outpatient Prospective Payment System Drug Acquisition Cost Survey and urged CMS to correct an FAQ issued on the issue.
Fact Sheet: The 340B Drug Pricing Program
Learn what the HHS 340B Drug Pricing Program is and what 340B hospitals are. The program allows 340B hospitals to stretch limited federal resources to reduce the price of outpatient pharmaceuticals for patients by providing 340B drug pricing discounts and expand health services to the patients and communities they serve.
AHA 340B Advocacy Alliance Bulletin - January 7, 2026
The United States Court of Appeals for the First Circuit today denied the government’s motion for a stay in a lawsuit filed by the AHA, the Maine Hospital Association, and four safety-net health systems challenging the 340B Rebate Model Pilot Program.
District Court Rules to Halt 340B Rebate Program
The U.S. District Court of Maine today granted a preliminary injunction blocking implementation of the Department of Health and Human Services 340B Rebate Model Pilot Program.
AHA 340B Advocacy Alliance Bulletin: Judge Rules to Halt 340B Rebate Model Program
The U.S. District Court of Maine today granted a preliminary injunction blocking implementation of the Department of Health and Human Services 340B Rebate Model Pilot Program.
AHA 340B Advocacy Alliance Bulletin - December 16, 2025
AHA 340B Advocacy Alliance Bulletin - December 16, 2025.
AHA 340B Advocacy Alliance
A Bloomberg article published today (linked here and text below) discusses how the Department of Health and Human Services plans to “survey safety-net hospitals on the amount they pay for prescription drugs, following up on an effort to reduce the hospitals’ Medicare drug reimbursement during the president’s first term.”